Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Measles and rubella vaccine microneedle patch - Micron Biomedical

Next Previous
Search
Drug Profile

Measles and rubella vaccine microneedle patch - Micron Biomedical

Alternative Names: measles-rubella (MR) vaccine microneedle patch - Micron Biomedical; MRV-MNP

Latest Information Update: 24 May 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Micron Biomedical
  • Class Measles vaccines; Rubella vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Measles; Rubella

Most Recent Events

  • 17 May 2023 Adverse events and Immunogenicity data from a phase I/II trial in Measles and Rubella released by Micron Biomedical
  • 31 Dec 2022 Micron Biomedical completes a phase I/II trial in Measles (Prevention, In adults, In infants) and Rubella (Prevention, In adults, In infants) in Gambia (Intradermal) (NCT04394689)
  • 13 Jul 2021 Phase-I/II clinical trials in Measles (Prevention, In adults, In infants) in Gambia (Intradermal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top